Kolon TissueGene (950160) surged over 11% on the 31st, the last trading day of July, recovering the 13,000-won level.

During the regular session, Kolon TissueGene closed at 13,000 won, up 1,330 won (11.40%) from the previous trading day. During intraday trading, it soared to as high as 13,280 won, demonstrating strong upward momentum.

Kolon TissueGene, which had recently dropped to the 11,000-won level, has reclaimed the 13,000-won range with this rebound, drawing investors' attention. The market is closely watching whether the upward trend will continue on the first trading day of August.

Overall market investment sentiment is cited as a key variable that will determine the short-term direction of the stock, and future developments related to TG-C clinical trials are also expected to be closely monitored.

[※ This article is not intended to solicit investment, and the final decision and responsibility for investments lie with the investor.]